Skip to main content
Article
72 Routine use of comprehensive genomic profiling to assess tumor mutational burden across a community health system
Journal for ImmunoTherapy of Cancer (2020)
  • Carlo Bifulco, Providence St. Joseph Health, Portland, OR, USA
  • Roshanthi Weerasinghe, Providence St. Joseph Health, Portland, OR, USA
  • Bela Bapat, Illumina
  • Alexa K Dowdell, Providence St. Joseph Health, Portland, OR, USA
  • Shwetha Pindikuri, Providence St. Joseph Health, Portland, OR, USA
  • Sheila Reynolds, Providence St. Joseph Health, Portland, OR, USA
  • Nancy Biery, Providence St. Joseph Health, Portland, OR, USA
  • David Ball, Providence St. Joseph Health, Portland, OR, USA
  • Mary Campbell, Providence St. Joseph Health, Portland, OR, USA
  • Thomas R Ward, Providence St. Joseph Health, Portland, OR, USA
  • Alisha Stein, Illumina
  • Brock Schroeder, Illumina
  • David Eberhard, Illumina
  • Brian D. Piening, Providence St. Joseph Health, Portland, OR, USA
Publication Date
November 1, 2020
DOI
10.1136/JITC-2020-SITC2020.0072
Citation Information
Carlo Bifulco, Roshanthi Weerasinghe, Bela Bapat, Alexa K Dowdell, et al.. "72 Routine use of comprehensive genomic profiling to assess tumor mutational burden across a community health system" Journal for ImmunoTherapy of Cancer Vol. 8 (2020)
Available at: http://works.bepress.com/brian-piening/11/